Clinical trial
Vyvanse and Glucose Intolerance in Children With ADHD and Obesity
NCT01017263 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vyvanse and Glucose Intolerance in Children With ADHD and Obesity
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- December 31, 2009
- Completion date
- August 31, 2012
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder, glucose intolerance, obesity